1. Home
  2. LITB vs CTXR Comparison

LITB vs CTXR Comparison

Compare LITB & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • CTXR
  • Stock Information
  • Founded
  • LITB 2007
  • CTXR 2007
  • Country
  • LITB Singapore
  • CTXR United States
  • Employees
  • LITB N/A
  • CTXR 23
  • Industry
  • LITB Catalog/Specialty Distribution
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITB Consumer Discretionary
  • CTXR Health Care
  • Exchange
  • LITB Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • LITB 21.7M
  • CTXR 20.8M
  • IPO Year
  • LITB N/A
  • CTXR N/A
  • Fundamental
  • Price
  • LITB $1.61
  • CTXR $1.15
  • Analyst Decision
  • LITB
  • CTXR Strong Buy
  • Analyst Count
  • LITB 0
  • CTXR 3
  • Target Price
  • LITB N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • LITB 49.7K
  • CTXR 477.0K
  • Earning Date
  • LITB 09-10-2025
  • CTXR 08-12-2025
  • Dividend Yield
  • LITB N/A
  • CTXR N/A
  • EPS Growth
  • LITB N/A
  • CTXR N/A
  • EPS
  • LITB 0.08
  • CTXR N/A
  • Revenue
  • LITB $231,136,000.00
  • CTXR N/A
  • Revenue This Year
  • LITB N/A
  • CTXR N/A
  • Revenue Next Year
  • LITB N/A
  • CTXR $851.67
  • P/E Ratio
  • LITB $16.17
  • CTXR N/A
  • Revenue Growth
  • LITB N/A
  • CTXR N/A
  • 52 Week Low
  • LITB $0.91
  • CTXR $0.65
  • 52 Week High
  • LITB $4.80
  • CTXR $15.25
  • Technical
  • Relative Strength Index (RSI)
  • LITB 73.73
  • CTXR 39.44
  • Support Level
  • LITB $1.17
  • CTXR $1.23
  • Resistance Level
  • LITB $1.27
  • CTXR $1.57
  • Average True Range (ATR)
  • LITB 0.12
  • CTXR 0.12
  • MACD
  • LITB 0.03
  • CTXR -0.01
  • Stochastic Oscillator
  • LITB 67.38
  • CTXR 10.64

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: